CRISTAL (a cluster-randomised, crossover, non-inferiority trial of aspirin compared to low molecular weight heparin for venous thromboembolism prophylaxis in hip or knee arthroplasty, a registry nested study): statistical analysis plan
ConclusionsThis paper provides a detailed statistical analysis plan for CRISTAL.Trial registrationAustralian and New Zealand Clinical Trials RegistryACTRN12618001879257. Registered on 19/11/2018. (Source: Trials)
Source: Trials - August 24, 2021 Category: Research Source Type: clinical trials
Venous Thromboembolism Prophylaxis After Gynecological Pelvic Cancer Surgery With Rivaroxaban vs Enoxaparin
Conditions: Cancer; Rivaroxaban; Venous Thromboembolism; Thromboprophylaxis Interventions: Drug: Rivaroxaban; Drug: Enoxaparin Sponsors: André Luiz Malavasi Longo de Oliveira; Science Valley Research Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2021 Category: Research Source Type: clinical trials
Anthos Therapeutics' Novel Factor XI Inhibitor Abelacimab Significantly Outperforms Standard of Care Enoxaparin in Prospective Phase 2 Efficacy Research Published in NEJM
CAMBRIDGE, Mass., July 19, 2021 /PRNewswire/ -- Anthos Therapeutics, a clinical-stage biopharma company developing innovative therapies for cardiovascular and metabolic diseases, today announced final results from the Phase 2 ANT-005... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - July 19, 2021 Category: Pharmaceuticals Source Type: clinical trials
